インスリン製剤の世界市場インサイト・予測(~2028年)

【英語タイトル】Global Insulin Preparation Market Insights, Forecast to 2028

QYResearchが出版した調査資料(QY22MA00001)・商品コード:QY22MA00001
・発行会社(調査会社):QYResearch
・発行日:2022年3月
・ページ数:108
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥725,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥1,087,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,450,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

新型コロナウイルス感染症のパンデミックにより、世界のインスリン製剤の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx%で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にインスリン製剤の世界市場のxxx%を占める「速効型」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx%CAGRで成長すると予測されています。一方、「病院薬局」セグメントは、この予測期間を通じてxxx%のCAGRに変更されます。
中国のインスリン製剤の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのインスリン製剤市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx%であり、中国とヨーロッパはそれぞれxxx%とxxx%です。中国の割合は2028年にxxx%に達し、対象期間を通じてxxx%のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx%、xxx%、xxx%になる見通しです。ヨーロッパのインスリン製剤市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx%になる見通しです。

インスリン製剤のグローバル主要メーカーには、Novo Nordisk、Sanofi-Aventis、Eli Lilly、Tonghua Dongbao、Ganlee、United Laboratory、Biocon、Amphastar、Wockhardt、Julphar Diabetesなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。

インスリン製剤市場は、種類と用途によって区分されます。世界のインスリン製剤市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
速効型、中効型、長時間型

【用途別セグメント】
病院薬局、小売店薬局、その他

【掲載地域】
北米:アメリカ、カナダ
ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米:メキシコ、ブラジル、アルゼンチン
中東・アフリカ:トルコ、サウジアラビア、UAE

【目次(一部)】

・調査の範囲
- インスリン製剤製品概要
- 種類別市場(速効型、中効型、長時間型)
- 用途別市場(病院薬局、小売店薬局、その他)
- 調査の目的
・エグゼクティブサマリー
- 世界のインスリン製剤販売量予測2017-2028
- 世界のインスリン製剤売上予測2017-2028
- インスリン製剤の地域別販売量
- インスリン製剤の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別インスリン製剤販売量
- 主要メーカー別インスリン製剤売上
- 主要メーカー別インスリン製剤価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模(速効型、中効型、長時間型)
- インスリン製剤の種類別販売量
- インスリン製剤の種類別売上
- インスリン製剤の種類別価格
・用途別市場規模(病院薬局、小売店薬局、その他)
- インスリン製剤の用途別販売量
- インスリン製剤の用途別売上
- インスリン製剤の用途別価格
・北米市場
- 北米のインスリン製剤市場規模(種類別、用途別)
- 主要国別のインスリン製剤市場規模(アメリカ、カナダ)
・ヨーロッパ市場
- ヨーロッパのインスリン製剤市場規模(種類別、用途別)
- 主要国別のインスリン製剤市場規模(ドイツ、フランス、イギリス、イタリア、ロシア)
・アジア太平洋市場
- アジア太平洋のインスリン製剤市場規模(種類別、用途別)
- 主要国別のインスリン製剤市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア)
・中南米市場
- 中南米のインスリン製剤市場規模(種類別、用途別)
- 主要国別のインスリン製剤市場規模(メキシコ、ブラジル、アルゼンチン)
・中東・アフリカ市場
- 中東・アフリカのインスリン製剤市場規模(種類別、用途別)
- 主要国別のインスリン製剤市場規模(トルコ、サウジアラビア)
・企業情報
Novo Nordisk、Sanofi-Aventis、Eli Lilly、Tonghua Dongbao、Ganlee、United Laboratory、Biocon、Amphastar、Wockhardt、Julphar Diabetes
・産業チェーン及び販売チャネル分析
- インスリン製剤の産業チェーン分析
- インスリン製剤の原材料
- インスリン製剤の生産プロセス
- インスリン製剤の販売及びマーケティング
- インスリン製剤の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- インスリン製剤の産業動向
- インスリン製剤のマーケットドライバー
- インスリン製剤の課題
- インスリン製剤の阻害要因
・主な調査結果

Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes. In China and Chinese insulin market, animal insulin, called first generation insulin, has been almost replaced by new type generation insulin.
Market Analysis and Insights: Global Insulin Preparation Market
Due to the COVID-19 pandemic, the global Insulin Preparation market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Fast-acting accounting for % of the Insulin Preparation global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital Pharmacy segment is altered to an % CAGR throughout this forecast period.
China Insulin Preparation market size is valued at US$ million in 2021, while the US and Europe Insulin Preparation are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Insulin Preparation landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Insulin Preparation include Novo Nordisk, Sanofi-Aventis, Eli Lilly, Tonghua Dongbao, Ganlee, United Laboratory, Biocon, Amphastar and Wockhardt and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Insulin Preparation Scope and Segment
Insulin Preparation market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Insulin Preparation market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Fast-acting
Intermediate-acting
Long-acting
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Other
By Company
Novo Nordisk
Sanofi-Aventis
Eli Lilly
Tonghua Dongbao
Ganlee
United Laboratory
Biocon
Amphastar
Wockhardt
Julphar Diabetes
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

❖ レポートの目次 ❖

1 Study Coverage
1.1 Insulin Preparation Product Introduction
1.2 Market by Type
1.2.1 Global Insulin Preparation Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Fast-acting
1.2.3 Intermediate-acting
1.2.4 Long-acting
1.3 Market by Application
1.3.1 Global Insulin Preparation Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Insulin Preparation Sales Estimates and Forecasts 2017-2028
2.2 Global Insulin Preparation Revenue Estimates and Forecasts 2017-2028
2.3 Global Insulin Preparation Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Insulin Preparation Sales by Region
2.4.1 Global Insulin Preparation Sales by Region (2017-2022)
2.4.2 Global Sales Insulin Preparation by Region (2023-2028)
2.5 Global Insulin Preparation Revenue by Region
2.5.1 Global Insulin Preparation Revenue by Region (2017-2022)
2.5.2 Global Insulin Preparation Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Insulin Preparation Sales by Manufacturers
3.1.1 Global Top Insulin Preparation Manufacturers by Sales (2017-2022)
3.1.2 Global Insulin Preparation Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Insulin Preparation in 2021
3.2 Global Insulin Preparation Revenue by Manufacturers
3.2.1 Global Insulin Preparation Revenue by Manufacturers (2017-2022)
3.2.2 Global Insulin Preparation Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Insulin Preparation Revenue in 2021
3.3 Global Insulin Preparation Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Insulin Preparation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Insulin Preparation Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Insulin Preparation Sales by Type
4.1.1 Global Insulin Preparation Historical Sales by Type (2017-2022)
4.1.2 Global Insulin Preparation Forecasted Sales by Type (2023-2028)
4.1.3 Global Insulin Preparation Sales Market Share by Type (2017-2028)
4.2 Global Insulin Preparation Revenue by Type
4.2.1 Global Insulin Preparation Historical Revenue by Type (2017-2022)
4.2.2 Global Insulin Preparation Forecasted Revenue by Type (2023-2028)
4.2.3 Global Insulin Preparation Revenue Market Share by Type (2017-2028)
4.3 Global Insulin Preparation Price by Type
4.3.1 Global Insulin Preparation Price by Type (2017-2022)
4.3.2 Global Insulin Preparation Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Insulin Preparation Sales by Application
5.1.1 Global Insulin Preparation Historical Sales by Application (2017-2022)
5.1.2 Global Insulin Preparation Forecasted Sales by Application (2023-2028)
5.1.3 Global Insulin Preparation Sales Market Share by Application (2017-2028)
5.2 Global Insulin Preparation Revenue by Application
5.2.1 Global Insulin Preparation Historical Revenue by Application (2017-2022)
5.2.2 Global Insulin Preparation Forecasted Revenue by Application (2023-2028)
5.2.3 Global Insulin Preparation Revenue Market Share by Application (2017-2028)
5.3 Global Insulin Preparation Price by Application
5.3.1 Global Insulin Preparation Price by Application (2017-2022)
5.3.2 Global Insulin Preparation Price Forecast by Application (2023-2028)
6 North America
6.1 North America Insulin Preparation Market Size by Type
6.1.1 North America Insulin Preparation Sales by Type (2017-2028)
6.1.2 North America Insulin Preparation Revenue by Type (2017-2028)
6.2 North America Insulin Preparation Market Size by Application
6.2.1 North America Insulin Preparation Sales by Application (2017-2028)
6.2.2 North America Insulin Preparation Revenue by Application (2017-2028)
6.3 North America Insulin Preparation Market Size by Country
6.3.1 North America Insulin Preparation Sales by Country (2017-2028)
6.3.2 North America Insulin Preparation Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Insulin Preparation Market Size by Type
7.1.1 Europe Insulin Preparation Sales by Type (2017-2028)
7.1.2 Europe Insulin Preparation Revenue by Type (2017-2028)
7.2 Europe Insulin Preparation Market Size by Application
7.2.1 Europe Insulin Preparation Sales by Application (2017-2028)
7.2.2 Europe Insulin Preparation Revenue by Application (2017-2028)
7.3 Europe Insulin Preparation Market Size by Country
7.3.1 Europe Insulin Preparation Sales by Country (2017-2028)
7.3.2 Europe Insulin Preparation Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Insulin Preparation Market Size by Type
8.1.1 Asia Pacific Insulin Preparation Sales by Type (2017-2028)
8.1.2 Asia Pacific Insulin Preparation Revenue by Type (2017-2028)
8.2 Asia Pacific Insulin Preparation Market Size by Application
8.2.1 Asia Pacific Insulin Preparation Sales by Application (2017-2028)
8.2.2 Asia Pacific Insulin Preparation Revenue by Application (2017-2028)
8.3 Asia Pacific Insulin Preparation Market Size by Region
8.3.1 Asia Pacific Insulin Preparation Sales by Region (2017-2028)
8.3.2 Asia Pacific Insulin Preparation Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Insulin Preparation Market Size by Type
9.1.1 Latin America Insulin Preparation Sales by Type (2017-2028)
9.1.2 Latin America Insulin Preparation Revenue by Type (2017-2028)
9.2 Latin America Insulin Preparation Market Size by Application
9.2.1 Latin America Insulin Preparation Sales by Application (2017-2028)
9.2.2 Latin America Insulin Preparation Revenue by Application (2017-2028)
9.3 Latin America Insulin Preparation Market Size by Country
9.3.1 Latin America Insulin Preparation Sales by Country (2017-2028)
9.3.2 Latin America Insulin Preparation Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Insulin Preparation Market Size by Type
10.1.1 Middle East and Africa Insulin Preparation Sales by Type (2017-2028)
10.1.2 Middle East and Africa Insulin Preparation Revenue by Type (2017-2028)
10.2 Middle East and Africa Insulin Preparation Market Size by Application
10.2.1 Middle East and Africa Insulin Preparation Sales by Application (2017-2028)
10.2.2 Middle East and Africa Insulin Preparation Revenue by Application (2017-2028)
10.3 Middle East and Africa Insulin Preparation Market Size by Country
10.3.1 Middle East and Africa Insulin Preparation Sales by Country (2017-2028)
10.3.2 Middle East and Africa Insulin Preparation Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Novo Nordisk
11.1.1 Novo Nordisk Corporation Information
11.1.2 Novo Nordisk Overview
11.1.3 Novo Nordisk Insulin Preparation Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Novo Nordisk Insulin Preparation Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Novo Nordisk Recent Developments
11.2 Sanofi-Aventis
11.2.1 Sanofi-Aventis Corporation Information
11.2.2 Sanofi-Aventis Overview
11.2.3 Sanofi-Aventis Insulin Preparation Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Sanofi-Aventis Insulin Preparation Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Sanofi-Aventis Recent Developments
11.3 Eli Lilly
11.3.1 Eli Lilly Corporation Information
11.3.2 Eli Lilly Overview
11.3.3 Eli Lilly Insulin Preparation Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Eli Lilly Insulin Preparation Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Eli Lilly Recent Developments
11.4 Tonghua Dongbao
11.4.1 Tonghua Dongbao Corporation Information
11.4.2 Tonghua Dongbao Overview
11.4.3 Tonghua Dongbao Insulin Preparation Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Tonghua Dongbao Insulin Preparation Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Tonghua Dongbao Recent Developments
11.5 Ganlee
11.5.1 Ganlee Corporation Information
11.5.2 Ganlee Overview
11.5.3 Ganlee Insulin Preparation Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Ganlee Insulin Preparation Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Ganlee Recent Developments
11.6 United Laboratory
11.6.1 United Laboratory Corporation Information
11.6.2 United Laboratory Overview
11.6.3 United Laboratory Insulin Preparation Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 United Laboratory Insulin Preparation Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 United Laboratory Recent Developments
11.7 Biocon
11.7.1 Biocon Corporation Information
11.7.2 Biocon Overview
11.7.3 Biocon Insulin Preparation Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Biocon Insulin Preparation Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Biocon Recent Developments
11.8 Amphastar
11.8.1 Amphastar Corporation Information
11.8.2 Amphastar Overview
11.8.3 Amphastar Insulin Preparation Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Amphastar Insulin Preparation Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Amphastar Recent Developments
11.9 Wockhardt
11.9.1 Wockhardt Corporation Information
11.9.2 Wockhardt Overview
11.9.3 Wockhardt Insulin Preparation Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Wockhardt Insulin Preparation Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Wockhardt Recent Developments
11.10 Julphar Diabetes
11.10.1 Julphar Diabetes Corporation Information
11.10.2 Julphar Diabetes Overview
11.10.3 Julphar Diabetes Insulin Preparation Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Julphar Diabetes Insulin Preparation Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Julphar Diabetes Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Insulin Preparation Industry Chain Analysis
12.2 Insulin Preparation Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Insulin Preparation Production Mode & Process
12.4 Insulin Preparation Sales and Marketing
12.4.1 Insulin Preparation Sales Channels
12.4.2 Insulin Preparation Distributors
12.5 Insulin Preparation Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Insulin Preparation Industry Trends
13.2 Insulin Preparation Market Drivers
13.3 Insulin Preparation Market Challenges
13.4 Insulin Preparation Market Restraints
14 Key Findings in The Global Insulin Preparation Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Insulin Preparation Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Fast-acting
Table 3. Major Manufacturers of Intermediate-acting
Table 4. Major Manufacturers of Long-acting
Table 5. Global Insulin Preparation Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Insulin Preparation Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Insulin Preparation Sales by Region (2017-2022) & (Units)
Table 8. Global Insulin Preparation Sales Market Share by Region (2017-2022)
Table 9. Global Insulin Preparation Sales by Region (2023-2028) & (Units)
Table 10. Global Insulin Preparation Sales Market Share by Region (2023-2028)
Table 11. Global Insulin Preparation Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Insulin Preparation Revenue Market Share by Region (2017-2022)
Table 13. Global Insulin Preparation Revenue by Region (2023-2028) & (US$ Million)
Table 14. Global Insulin Preparation Revenue Market Share by Region (2023-2028)
Table 15. Global Insulin Preparation Sales by Manufacturers (2017-2022) & (Units)
Table 16. Global Insulin Preparation Sales Share by Manufacturers (2017-2022)
Table 17. Global Insulin Preparation Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global Insulin Preparation Revenue Share by Manufacturers (2017-2022)
Table 19. Insulin Preparation Price by Manufacturers (2017-2022) &(US$/Unit)
Table 20. Global Insulin Preparation Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Insulin Preparation by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insulin Preparation as of 2021)
Table 22. Insulin Preparation Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Insulin Preparation Product Offered
Table 24. Date of Manufacturers Enter into Insulin Preparation Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Insulin Preparation Sales by Type (2017-2022) & (Units)
Table 27. Global Insulin Preparation Sales by Type (2023-2028) & (Units)
Table 28. Global Insulin Preparation Sales Share by Type (2017-2022)
Table 29. Global Insulin Preparation Sales Share by Type (2023-2028)
Table 30. Global Insulin Preparation Revenue by Type (2017-2022) & (US$ Million)
Table 31. Global Insulin Preparation Revenue by Type (2023-2028) & (US$ Million)
Table 32. Global Insulin Preparation Revenue Share by Type (2017-2022)
Table 33. Global Insulin Preparation Revenue Share by Type (2023-2028)
Table 34. Insulin Preparation Price by Type (2017-2022) & (US$/Unit)
Table 35. Global Insulin Preparation Price Forecast by Type (2023-2028) & (US$/Unit)
Table 36. Global Insulin Preparation Sales by Application (2017-2022) & (Units)
Table 37. Global Insulin Preparation Sales by Application (2023-2028) & (Units)
Table 38. Global Insulin Preparation Sales Share by Application (2017-2022)
Table 39. Global Insulin Preparation Sales Share by Application (2023-2028)
Table 40. Global Insulin Preparation Revenue by Application (2017-2022) & (US$ Million)
Table 41. Global Insulin Preparation Revenue by Application (2023-2028) & (US$ Million)
Table 42. Global Insulin Preparation Revenue Share by Application (2017-2022)
Table 43. Global Insulin Preparation Revenue Share by Application (2023-2028)
Table 44. Insulin Preparation Price by Application (2017-2022) & (US$/Unit)
Table 45. Global Insulin Preparation Price Forecast by Application (2023-2028) & (US$/Unit)
Table 46. North America Insulin Preparation Sales by Type (2017-2022) & (Units)
Table 47. North America Insulin Preparation Sales by Type (2023-2028) & (Units)
Table 48. North America Insulin Preparation Revenue by Type (2017-2022) & (US$ Million)
Table 49. North America Insulin Preparation Revenue by Type (2023-2028) & (US$ Million)
Table 50. North America Insulin Preparation Sales by Application (2017-2022) & (Units)
Table 51. North America Insulin Preparation Sales by Application (2023-2028) & (Units)
Table 52. North America Insulin Preparation Revenue by Application (2017-2022) & (US$ Million)
Table 53. North America Insulin Preparation Revenue by Application (2023-2028) & (US$ Million)
Table 54. North America Insulin Preparation Sales by Country (2017-2022) & (Units)
Table 55. North America Insulin Preparation Sales by Country (2023-2028) & (Units)
Table 56. North America Insulin Preparation Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America Insulin Preparation Revenue by Country (2023-2028) & (US$ Million)
Table 58. Europe Insulin Preparation Sales by Type (2017-2022) & (Units)
Table 59. Europe Insulin Preparation Sales by Type (2023-2028) & (Units)
Table 60. Europe Insulin Preparation Revenue by Type (2017-2022) & (US$ Million)
Table 61. Europe Insulin Preparation Revenue by Type (2023-2028) & (US$ Million)
Table 62. Europe Insulin Preparation Sales by Application (2017-2022) & (Units)
Table 63. Europe Insulin Preparation Sales by Application (2023-2028) & (Units)
Table 64. Europe Insulin Preparation Revenue by Application (2017-2022) & (US$ Million)
Table 65. Europe Insulin Preparation Revenue by Application (2023-2028) & (US$ Million)
Table 66. Europe Insulin Preparation Sales by Country (2017-2022) & (Units)
Table 67. Europe Insulin Preparation Sales by Country (2023-2028) & (Units)
Table 68. Europe Insulin Preparation Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe Insulin Preparation Revenue by Country (2023-2028) & (US$ Million)
Table 70. Asia Pacific Insulin Preparation Sales by Type (2017-2022) & (Units)
Table 71. Asia Pacific Insulin Preparation Sales by Type (2023-2028) & (Units)
Table 72. Asia Pacific Insulin Preparation Revenue by Type (2017-2022) & (US$ Million)
Table 73. Asia Pacific Insulin Preparation Revenue by Type (2023-2028) & (US$ Million)
Table 74. Asia Pacific Insulin Preparation Sales by Application (2017-2022) & (Units)
Table 75. Asia Pacific Insulin Preparation Sales by Application (2023-2028) & (Units)
Table 76. Asia Pacific Insulin Preparation Revenue by Application (2017-2022) & (US$ Million)
Table 77. Asia Pacific Insulin Preparation Revenue by Application (2023-2028) & (US$ Million)
Table 78. Asia Pacific Insulin Preparation Sales by Region (2017-2022) & (Units)
Table 79. Asia Pacific Insulin Preparation Sales by Region (2023-2028) & (Units)
Table 80. Asia Pacific Insulin Preparation Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific Insulin Preparation Revenue by Region (2023-2028) & (US$ Million)
Table 82. Latin America Insulin Preparation Sales by Type (2017-2022) & (Units)
Table 83. Latin America Insulin Preparation Sales by Type (2023-2028) & (Units)
Table 84. Latin America Insulin Preparation Revenue by Type (2017-2022) & (US$ Million)
Table 85. Latin America Insulin Preparation Revenue by Type (2023-2028) & (US$ Million)
Table 86. Latin America Insulin Preparation Sales by Application (2017-2022) & (Units)
Table 87. Latin America Insulin Preparation Sales by Application (2023-2028) & (Units)
Table 88. Latin America Insulin Preparation Revenue by Application (2017-2022) & (US$ Million)
Table 89. Latin America Insulin Preparation Revenue by Application (2023-2028) & (US$ Million)
Table 90. Latin America Insulin Preparation Sales by Country (2017-2022) & (Units)
Table 91. Latin America Insulin Preparation Sales by Country (2023-2028) & (Units)
Table 92. Latin America Insulin Preparation Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America Insulin Preparation Revenue by Country (2023-2028) & (US$ Million)
Table 94. Middle East and Africa Insulin Preparation Sales by Type (2017-2022) & (Units)
Table 95. Middle East and Africa Insulin Preparation Sales by Type (2023-2028) & (Units)
Table 96. Middle East and Africa Insulin Preparation Revenue by Type (2017-2022) & (US$ Million)
Table 97. Middle East and Africa Insulin Preparation Revenue by Type (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Insulin Preparation Sales by Application (2017-2022) & (Units)
Table 99. Middle East and Africa Insulin Preparation Sales by Application (2023-2028) & (Units)
Table 100. Middle East and Africa Insulin Preparation Revenue by Application (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Insulin Preparation Revenue by Application (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Insulin Preparation Sales by Country (2017-2022) & (Units)
Table 103. Middle East and Africa Insulin Preparation Sales by Country (2023-2028) & (Units)
Table 104. Middle East and Africa Insulin Preparation Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Insulin Preparation Revenue by Country (2023-2028) & (US$ Million)
Table 106. Novo Nordisk Corporation Information
Table 107. Novo Nordisk Description and Major Businesses
Table 108. Novo Nordisk Insulin Preparation Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 109. Novo Nordisk Insulin Preparation Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. Novo Nordisk Recent Developments
Table 111. Sanofi-Aventis Corporation Information
Table 112. Sanofi-Aventis Description and Major Businesses
Table 113. Sanofi-Aventis Insulin Preparation Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 114. Sanofi-Aventis Insulin Preparation Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Sanofi-Aventis Recent Developments
Table 116. Eli Lilly Corporation Information
Table 117. Eli Lilly Description and Major Businesses
Table 118. Eli Lilly Insulin Preparation Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 119. Eli Lilly Insulin Preparation Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Eli Lilly Recent Developments
Table 121. Tonghua Dongbao Corporation Information
Table 122. Tonghua Dongbao Description and Major Businesses
Table 123. Tonghua Dongbao Insulin Preparation Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 124. Tonghua Dongbao Insulin Preparation Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Tonghua Dongbao Recent Developments
Table 126. Ganlee Corporation Information
Table 127. Ganlee Description and Major Businesses
Table 128. Ganlee Insulin Preparation Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 129. Ganlee Insulin Preparation Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Ganlee Recent Developments
Table 131. United Laboratory Corporation Information
Table 132. United Laboratory Description and Major Businesses
Table 133. United Laboratory Insulin Preparation Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 134. United Laboratory Insulin Preparation Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. United Laboratory Recent Developments
Table 136. Biocon Corporation Information
Table 137. Biocon Description and Major Businesses
Table 138. Biocon Insulin Preparation Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 139. Biocon Insulin Preparation Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. Biocon Recent Developments
Table 141. Amphastar Corporation Information
Table 142. Amphastar Description and Major Businesses
Table 143. Amphastar Insulin Preparation Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 144. Amphastar Insulin Preparation Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. Amphastar Recent Developments
Table 146. Wockhardt Corporation Information
Table 147. Wockhardt Description and Major Businesses
Table 148. Wockhardt Insulin Preparation Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 149. Wockhardt Insulin Preparation Product Model Numbers, Pictures, Descriptions and Specifications
Table 150. Wockhardt Recent Developments
Table 151. Julphar Diabetes Corporation Information
Table 152. Julphar Diabetes Description and Major Businesses
Table 153. Julphar Diabetes Insulin Preparation Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 154. Julphar Diabetes Insulin Preparation Product Model Numbers, Pictures, Descriptions and Specifications
Table 155. Julphar Diabetes Recent Developments
Table 156. Key Raw Materials Lists
Table 157. Raw Materials Key Suppliers Lists
Table 158. Insulin Preparation Distributors List
Table 159. Insulin Preparation Customers List
Table 160. Insulin Preparation Market Trends
Table 161. Insulin Preparation Market Drivers
Table 162. Insulin Preparation Market Challenges
Table 163. Insulin Preparation Market Restraints
Table 164. Research Programs/Design for This Report
Table 165. Key Data Information from Secondary Sources
Table 166. Key Data Information from Primary Sources
List of Figures
Figure 1. Insulin Preparation Product Picture
Figure 3. Global Insulin Preparation Market Share by Type in 2021 & 2028
Figure 3. Fast-acting Product Picture
Figure 4. Intermediate-acting Product Picture
Figure 5. Long-acting Product Picture
Figure 6. Global Insulin Preparation Market Share by Application in 2021 & 2028
Figure 7. Hospital Pharmacy
Figure 8. Retail Pharmacy
Figure 9. Other
Figure 10. Insulin Preparation Report Years Considered
Figure 11. Global Insulin Preparation Sales 2017-2028 (Units)
Figure 12. Global Insulin Preparation Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Insulin Preparation Revenue 2017-2028 (US$ Million)
Figure 14. Global Insulin Preparation Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 15. Global Insulin Preparation Sales Market Share by Region (2017-2022)
Figure 16. Global Insulin Preparation Sales Market Share by Region (2023-2028)
Figure 17. North America Insulin Preparation Sales YoY (2017-2028) & (Units)
Figure 18. North America Insulin Preparation Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Europe Insulin Preparation Sales YoY (2017-2028) & (Units)
Figure 20. Europe Insulin Preparation Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Asia-Pacific Insulin Preparation Sales YoY (2017-2028) & (Units)
Figure 22. Asia-Pacific Insulin Preparation Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Latin America Insulin Preparation Sales YoY (2017-2028) & (Units)
Figure 24. Latin America Insulin Preparation Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Middle East & Africa Insulin Preparation Sales YoY (2017-2028) & (Units)
Figure 26. Middle East & Africa Insulin Preparation Revenue YoY (2017-2028) & (US$ Million)
Figure 27. The Insulin Preparation Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 28. The Top 5 and 10 Largest Manufacturers of Insulin Preparation in the World: Market Share by Insulin Preparation Revenue in 2021
Figure 29. Global Insulin Preparation Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 30. Global Insulin Preparation Sales Market Share by Type (2017-2028)
Figure 31. Global Insulin Preparation Revenue Market Share by Type (2017-2028)
Figure 32. Global Insulin Preparation Sales Market Share by Application (2017-2028)
Figure 33. Global Insulin Preparation Revenue Market Share by Application (2017-2028)
Figure 34. North America Insulin Preparation Sales Market Share by Type (2017-2028)
Figure 35. North America Insulin Preparation Revenue Market Share by Type (2017-2028)
Figure 36. North America Insulin Preparation Sales Market Share by Application (2017-2028)
Figure 37. North America Insulin Preparation Revenue Market Share by Application (2017-2028)
Figure 38. North America Insulin Preparation Sales Share by Country (2017-2028)
Figure 39. North America Insulin Preparation Revenue Share by Country (2017-2028)
Figure 40. United States Insulin Preparation Revenue (2017-2028) & (US$ Million)
Figure 41. Canada Insulin Preparation Revenue (2017-2028) & (US$ Million)
Figure 42. Europe Insulin Preparation Sales Market Share by Type (2017-2028)
Figure 43. Europe Insulin Preparation Revenue Market Share by Type (2017-2028)
Figure 44. Europe Insulin Preparation Sales Market Share by Application (2017-2028)
Figure 45. Europe Insulin Preparation Revenue Market Share by Application (2017-2028)
Figure 46. Europe Insulin Preparation Sales Share by Country (2017-2028)
Figure 47. Europe Insulin Preparation Revenue Share by Country (2017-2028)
Figure 48. Germany Insulin Preparation Revenue (2017-2028) & (US$ Million)
Figure 49. France Insulin Preparation Revenue (2017-2028) & (US$ Million)
Figure 50. U.K. Insulin Preparation Revenue (2017-2028) & (US$ Million)
Figure 51. Italy Insulin Preparation Revenue (2017-2028) & (US$ Million)
Figure 52. Russia Insulin Preparation Revenue (2017-2028) & (US$ Million)
Figure 53. Asia Pacific Insulin Preparation Sales Market Share by Type (2017-2028)
Figure 54. Asia Pacific Insulin Preparation Revenue Market Share by Type (2017-2028)
Figure 55. Asia Pacific Insulin Preparation Sales Market Share by Application (2017-2028)
Figure 56. Asia Pacific Insulin Preparation Revenue Market Share by Application (2017-2028)
Figure 57. Asia Pacific Insulin Preparation Sales Share by Region (2017-2028)
Figure 58. Asia Pacific Insulin Preparation Revenue Share by Region (2017-2028)
Figure 59. China Insulin Preparation Revenue (2017-2028) & (US$ Million)
Figure 60. Japan Insulin Preparation Revenue (2017-2028) & (US$ Million)
Figure 61. South Korea Insulin Preparation Revenue (2017-2028) & (US$ Million)
Figure 62. India Insulin Preparation Revenue (2017-2028) & (US$ Million)
Figure 63. Australia Insulin Preparation Revenue (2017-2028) & (US$ Million)
Figure 64. China Taiwan Insulin Preparation Revenue (2017-2028) & (US$ Million)
Figure 65. Indonesia Insulin Preparation Revenue (2017-2028) & (US$ Million)
Figure 66. Thailand Insulin Preparation Revenue (2017-2028) & (US$ Million)
Figure 67. Malaysia Insulin Preparation Revenue (2017-2028) & (US$ Million)
Figure 68. Latin America Insulin Preparation Sales Market Share by Type (2017-2028)
Figure 69. Latin America Insulin Preparation Revenue Market Share by Type (2017-2028)
Figure 70. Latin America Insulin Preparation Sales Market Share by Application (2017-2028)
Figure 71. Latin America Insulin Preparation Revenue Market Share by Application (2017-2028)
Figure 72. Latin America Insulin Preparation Sales Share by Country (2017-2028)
Figure 73. Latin America Insulin Preparation Revenue Share by Country (2017-2028)
Figure 74. Mexico Insulin Preparation Revenue (2017-2028) & (US$ Million)
Figure 75. Brazil Insulin Preparation Revenue (2017-2028) & (US$ Million)
Figure 76. Argentina Insulin Preparation Revenue (2017-2028) & (US$ Million)
Figure 77. Middle East and Africa Insulin Preparation Sales Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Insulin Preparation Revenue Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Insulin Preparation Sales Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Insulin Preparation Revenue Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Insulin Preparation Sales Share by Country (2017-2028)
Figure 82. Middle East and Africa Insulin Preparation Revenue Share by Country (2017-2028)
Figure 83. Turkey Insulin Preparation Revenue (2017-2028) & (US$ Million)
Figure 84. Saudi Arabia Insulin Preparation Revenue (2017-2028) & (US$ Million)
Figure 85. UAE Insulin Preparation Revenue (2017-2028) & (US$ Million)
Figure 86. Insulin Preparation Value Chain
Figure 87. Insulin Preparation Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed


★調査レポート[インスリン製剤の世界市場インサイト・予測(~2028年)] (コード:QY22MA00001)販売に関する免責事項を必ずご確認ください。
★調査レポート[インスリン製剤の世界市場インサイト・予測(~2028年)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆